Division of Cardiology, Second Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan.
J Am Geriatr Soc. 2019 Feb;67(2):323-328. doi: 10.1111/jgs.15663. Epub 2018 Nov 14.
To evaluate the association between high estimated pulmonary artery systolic pressure (ePASP) obtained by echocardiography and 1-year mortality in patients with acute heart failure (HF), comparing findings in individuals aged 80 and older with those of individuals younger than 80.
Retrospective cohort study.
Kyorin University Hospital.
Individuals with acute decompensated HF (N = 335).
High ePASP was defined as a tricuspid regurgitation pressure gradient greater than 47 mmHg (ePASP >50 mmHg). Potential risk factors for 1-year mortality were selected using univariate analysis followed by multivariate Cox regression analysis with backward stepwise selection of variables with P < .10 on univariate analysis to identify significant factors.
In individuals aged 80 and older, high ePASP (hazard ratio (HR)=3.07; 95% confidence interval (CI)=1.21-7.80), discharge medications without diuretics (HR=4.18, 95% CI=1.66-10.54), and discharge medications without renin-angiotensin-aldosterone system inhibitors (HR=3.38, 95% CI=1.29-8.81) were independent risk factors for 1-year mortality. In contrast, low systolic blood pressure at admission was the sole independent risk factor for 1-year mortality (HR=0.94, 95% CI=0.89-0.99) in those younger than 80.
High ePASP is a significant predictor of 1-year mortality in individuals aged 80 and older with acute HF but not in those younger than 80. Elucidation of the pathophysiological mechanisms behind these findings should facilitate the development of more effective individualized therapies for older adults with acute HF. J Am Geriatr Soc 67:323-328, 2019.
通过超声心动图评估肺动脉收缩压估测值(ePASP)升高与急性心力衰竭(HF)患者 1 年死亡率的相关性,比较 80 岁及以上患者与 80 岁以下患者的结果。
回顾性队列研究。
桐荫医疗大学医院。
急性失代偿性 HF 患者(N=335)。
将三尖瓣反流压力梯度大于 47mmHg(ePASP>50mmHg)定义为高 ePASP。采用单因素分析选择潜在的 1 年死亡率危险因素,然后采用多元 Cox 回归分析,采用向后逐步选择单因素分析 P<0.10 的变量,以确定显著因素。
在 80 岁及以上患者中,高 ePASP(危险比(HR)=3.07;95%置信区间(CI)=1.21-7.80)、出院时无利尿剂(HR=4.18,95% CI=1.66-10.54)和出院时无肾素-血管紧张素-醛固酮系统抑制剂(HR=3.38,95% CI=1.29-8.81)是 1 年死亡率的独立危险因素。相比之下,80 岁以下患者中,入院时低收缩压是 1 年死亡率的唯一独立危险因素(HR=0.94,95% CI=0.89-0.99)。
在 80 岁及以上急性 HF 患者中,高 ePASP 是 1 年死亡率的重要预测指标,但在 80 岁以下患者中并非如此。阐明这些发现背后的病理生理机制,应有助于为老年急性 HF 患者制定更有效的个体化治疗方案。
美国老年医学会 67:323-328, 2019.